Venkataraman Ramesh
The CRISMA Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Room 642A, Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA.
Crit Care Clin. 2005 Apr;21(2):281-9. doi: 10.1016/j.ccc.2004.12.004.
Acute renal failure (ARF) complicates the clinical course of many critically ill patients and significantly adds to their morbidity and mortality. Efforts to develop techniques to prevent ARF or to facilitate its resolution largely have been unsuccessful. Aggressive hydration, minimizing nephrotoxins, and maintenance of "adequate" mean arterial pressure remain the main nonpharmacologic strategies to prevent ARF in the ICU. Increasing insight into mechanisms that lead to ARF prompted investigators to evaluate the role of novel therapeutic agents in the prevention of ARF. Recent data suggest that N-acetylcysteine may reduce the incidence of ARF secondary to radio-contrast agents.
急性肾衰竭(ARF)使许多危重症患者的临床病程复杂化,并显著增加其发病率和死亡率。开发预防ARF或促进其缓解的技术的努力大多未成功。积极补液、尽量减少肾毒素以及维持“足够”的平均动脉压仍然是重症监护病房预防ARF的主要非药物策略。对导致ARF的机制的深入了解促使研究人员评估新型治疗药物在预防ARF中的作用。最近的数据表明,N-乙酰半胱氨酸可能降低造影剂所致ARF的发生率。